A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →
Posts Tagged symlin
Latest TCOYD Newsletter
A new oral medication for T1D is awaiting FDA approval, and it’s shown fewer highs, fewer lows, and more predictable insulin dosing in recent studies.
read more →